Descriptor English: | Vancomycin-Resistant Staphylococcus aureus | ||||||
Descriptor Spanish: |
Staphylococcus aureus Resistente a Vancomicina
| ||||||
Descriptor Portuguese: | Staphylococcus aureus Resistente à Vancomicina | ||||||
Descriptor French: | Staphylococcus aureus résistant à la vancomycine | ||||||
Entry term(s): |
Glycopeptide-Intermediate S. aureus Glycopeptide-Intermediate Staphylococcus aureus Glycopeptide-Resistant S. aureus Glycopeptide-Resistant Staphylococcus aureus Vancomycin-Intermediate S. aureus Vancomycin-Intermediate Staphylococcus aureus Vancomycin-Resistant S. aureus |
||||||
Tree number(s): |
B03.300.390.400.800.750.100.750 B03.353.500.750.750.100.750 B03.510.100.750.750.100.750 B03.510.400.790.750.100.750 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000083123 | ||||||
Scope note: | Isolates of the Staphylococcus aureus that are resistant to the antibiotic VANCOMYCIN. The S. aureus becomes resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE. Vancomycin‐intermediate S. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. These S. aureus with reduced susceptibility to vancomycin and related GLYCOPEPTIDE antibiotics are often seen in HEALTHCARE ASSOCIATED INFECTIONS. |
||||||
Annotation: | infection: coordinate with STAPHYLOCOCCAL INFECTIONS or specifics |
||||||
Allowable Qualifiers: |
CH chemistry CL classification CY cytology DE drug effects EN enzymology GD growth & development GE genetics IM immunology IP isolation & purification ME metabolism PH physiology PY pathogenicity RE radiation effects UL ultrastructure VI virology |
||||||
Previous Indexing: |
Staphylococcus aureus (1999-2020) Vancomycin Resistance (1999-2020) |
||||||
Public MeSH Note: | 2021 |
||||||
History Note: | 2021 |
||||||
Related: |
Vancomycin Resistance
MeSH | ||||||
DeCS ID: | 59370 | ||||||
Unique ID: | D000083123 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2021/01/01 | ||||||
Date of Entry: | 2020/07/07 | ||||||
Revision Date: | 2020/02/28 |
-
-
ORGANISMS
Bacteria [B03]Bacteria -
ORGANISMS
Bacteria [B03]Bacteria -
ORGANISMS
Bacteria [B03]Bacteria -
ORGANISMS
Bacteria [B03]Bacteria
|
Vancomycin-Resistant Staphylococcus aureus
- Preferred
Vancomycin-Intermediate Staphylococcus aureus
- Related but not broader or narrower
Concept UI |
M000678699 |
Scope note | Isolates of the Staphylococcus aureus that are resistant to the antibiotic VANCOMYCIN. The S. aureus becomes resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE. Vancomycin‐intermediate S. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. These S. aureus with reduced susceptibility to vancomycin and related GLYCOPEPTIDE antibiotics are often seen in HEALTHCARE ASSOCIATED INFECTIONS. |
Preferred term | Vancomycin-Resistant Staphylococcus aureus |
Entry term(s) |
Glycopeptide-Resistant S. aureus Glycopeptide-Resistant Staphylococcus aureus Vancomycin-Resistant S. aureus |
Concept UI |
M000678717 |
Preferred term | Vancomycin-Intermediate Staphylococcus aureus |
Entry term(s) |
Glycopeptide-Intermediate S. aureus Glycopeptide-Intermediate Staphylococcus aureus Vancomycin-Intermediate S. aureus |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey